Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluoxetine for Quality of Life in Advanced NSCLC
NCT00005850Phase 2Completed
- Sponsor
- Cancer and Leukemia Group B
- Start
- Aug 2001
- Primary completion
- Sep 2003
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of fluoxetine in anxiety disorder, major depressive disorder (MDD), fatigue, sponsored by Cancer and Leukemia Group B. Started Aug 2001; status: completed.
02
Drugs
fluoxetine
03
Conditions
anxiety disordermajor depressive disorder (MDD)fatigue
Beyond the preview
Go deeper on NCT00005850.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00005850.